Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Gregory Smallwood"'
Autor:
Carlos G. Fasola, Rene Romero, Todd Pillen, Wenhao Tang, Stuart Henry, Gregory Smallwood, Katherine Casper, Thomas G. Heffron, Sundari Sekar, David Solis
Publikováno v:
Pediatric Transplantation. 14:722-729
PVT or PVS and HVOO are known causes of graft and patient loss after pediatric liver transplantation. Increased incidences of these complications have been reported in partial livers including DDSLT or LDLT. From 1997 to 2008, 241 consecutive pediatr
Autor:
Carlos G. Fasola, Nitika A. Gupta, John Rodriguez, Stuart Henry, Rene Romero, Miriam B. Vos, Katherine Casper, Sundari Sekar, Gregory Smallwood, Thomas G. Heffron, Todd Pillen
Publikováno v:
Pediatric Transplantation. 14:228-232
Children transplanted for ALF urgently require an optimal graft and have lower post-transplant survival compared with children transplanted for chronic liver disease. Over 10 yr, 33 consecutive children transplanted for ALF were followed. Demographic
Autor:
Carlos G. Fasola, John Rodriguez, Thomas G. Heffron, Katherine Casper, Gregory Smallwood, Jennifer Lehneman, A. Stieber
Publikováno v:
Liver Transplantation. 13:1396-1400
We present a case report of a cytomegalovirus (CMV)-seronegative, 58-year-old male who received a CMV-seropositive donor liver transplant without CMV prophylaxis. On postoperative day 30, the patient developed primary CMV disease that responded to ga
Autor:
Gregory Smallwood
Publikováno v:
Current Opinion in Organ Transplantation. 11:613-616
Autor:
Jill De Paolo, Thomas G. Heffron, Todd Pillen, Phil Hagedorn, Gregory Smallwood, Patricia Douglas, Alexander Duncan, Massimo Asolati, John Rodriguez, D Welch, James R. Spivey, Enrique Martinez, Carlos G. Fasola, Chang Nam, Mark Guy, Rene Romero
Publikováno v:
Liver Transplantation. 12:972-978
Transplanting blood group A, B, or O (ABO)-incompatible (ABO-I) liver grafts has resulted in lower patient and graft survival with an increased incidence of vascular and biliary complications and rejection. We report that, without modification of our
Autor:
George Atkinson, Thomas G. Heffron, Doug Redd, Stuart Henry, D Welch, Rene Romero, Enrique Martinez, Carlos G. Fasola, Gregory Smallwood, Changwoo Nam, Todd Pillen, Mark Guy
Publikováno v:
Pediatric Transplantation. 9:486-490
The risk of hepatic artery thrombosis (HAT) after pediatric liver transplantation (PLT) has been reported to range from 0 to 25%. We report our experience focusing on the interrelationships between risk factors, surgical technique and the incidence o
Publikováno v:
Pediatric Transplantation. 7:484-488
Reports indicate peripheral eosinophilia (PE) and gastrointestinal eosinophilic inflammation can occur after pediatric liver transplantation. The incidence of these conditions, potential risk factors, and the impact of PE and gastrointestinal eosinop
Publikováno v:
Transplantation. 75:2040-2043
Background. A new class of monoclonal antibodies (non-T-cell depleting) has gained favor for induction therapy after transplantation. This study evaluated the non-T-cell depleting antibody to the CD25 cell, daclizumab, as a single-dose induction agen
Autor:
Gregory Smallwood, Thomas G. Heffron
Publikováno v:
Current Opinion in Organ Transplantation. 6:338-342
Owing in part to successful long-term survival, the consequences of immunosuppression have gained wider attention from the transplant community. Both the micro-emulsified cyclosporine product and tacrolimus have been useful in decreasing rejection ep
Publikováno v:
Progress in Transplantation. 11:217-223
Because of troublesome side effects associated with steroid use, many transplant centers have tried to withdraw steroids from stable, solid organ transplant recipients. The objective of this study was to evaluate the ability to wean liver transplant